Colourful food increases vision for AMD patients

Article

Consuming dark-coloured fruits and vegetables increases the levels of macular pigment (MP) and is associated with improved vision in age-related macular degeneration (AMD) sufferers, according to study results published in the New Straits Times Online on September 22.

Consuming dark-coloured fruits and vegetables increases the levels of macular pigment (MP) and is associated with improved vision in age-related macular degeneration (AMD) sufferers, according to study results published in the New Straits Times Online on September 22.

The pilot study, conducted by the outpatient clinic of the Ophthalmology and Visual Sciences department at Alexandra Hospital in Singapore, measured the levels of MP in subjects aged ≥50 years (n=60; AMD, n=46) and found that high levels of MP were associated with better vision.

The carotenoids lutein and zeaxanthin, of which MP is composed, must be consumed and cannot be synthesized by the eye. The pigments occur in fruit and vegetables including pumpkin, green leafy vegetables, oranges and kiwi fruit.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.